Novartis committed to CAR-Ts – but doubts about commercial viability remainNovartis may have concerns about commercial prospects, says expert. Share XNovartis committed to CAR-Ts – but doubts about commercial viability remainhttps://pharmaphorum.com/views-and-analysis/will-car-t-profitable-pharma/